Horizon Technology Finance Corp(HRZN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 12.4 | EPS (ttm) | 0.33 | Insider Own | 0.54% | Shs Outstand | 67.0M | Perf Week | 2.78% |
| Market Cap | 0.27B | Forward P/E | 5.46 | EPS next Y | 10.33% | Insider Trans | 66.81% | Shs Float | 66.7M | Perf Month | -11.33% |
| Enterprise Value | 0.54B | PEG | - | EPS next Q | 0.18 | Inst Own | 11.63% | Short Float | 4.41% | Perf Quarter | -8.03% |
| Income | 0.01B | P/S | 6.2 | EPS this Y | -35.71% | Inst Trans | - | Short Ratio | 4.95 | Perf Half Y | -0.4% |
| Sales | 0.04B | P/B | 0.65 | EPS next 5Y | -11.66% | ROA | 0.65% | Short Interest | 2.94M | Perf YTD | -34.83% |
| Book/sh | 6.23 | P/C | 2.02 | EPS past 3/5Y | - | ROE | 1.45% | 52W High | -38.64% ($6.63) | Perf Year | -36.22% |
| Cash/sh | 2.01 | P/FCF | 1.55 | Sales past 3/5Y | -16.28% 5.47% | ROIC | 0.68% | 52W Low | 10.57% ($3.68) | Perf 3Y | -61.15% |
| Dividend Est. | $0.94 (23.22%) | EV/EBITDA | 12.04 | EPS Y/Y TTM | 134.12% | Gross Margin | 65.02% | Volatility(W/M) | 2.79% 2.81% | Perf 5Y | -75.55% |
| Dividend TTM | 0.9 | EV/Sales | 12.28 | Sales Y/Y TTM | -13.29% | Oper. Margin | 102% | ATR (14) | 0.13 | Perf 10Y | -66.83% |
| Dividend Ex-Date | 2026/11/17 | Quick Ratio | 1.69 | EPS Q/Q | -13.79% | Profit Margin | 11.52% | RSI (14) | 37.85 | Recom | 2.33 |
| Dividend Gr. 3/5Y | 2.94% 1.92% | Current Ratio | 1.69 | Sales Q/Q | 24.28% | SMA20 | -4.61% ($4.27) | Beta | 0.98 | Target Price | $5.08 |
| Payout | - | Debt/Eq | 0.96 | Earnings | 2026/11/5 | SMA50 | -9.7% ($4.51) | Rel Volume | 0.77 | Prev Close | $4.13 |
| Employees | - | LT Debt/Eq | 0.78 | EPS/Sales Surpr. | -12.77% -0.71% | SMA200 | -12.84% ($4.67) | Avg Volume(3M) | 0.59M | Price | $4.07 |
| IPO | 2010/10/29 | Option/Short | Yes/Yes | Trades | 2486 | Volume | 456,594 | Change | -1.45% |
💸 Horizon Technology Finance (ticker HRZN) is a US business development company that provides growth capital loans to venture-stage companies in the technology, life sciences, and healthcare IT sectors. Its dual income structure stands out, generating revenue from loan interest while also holding warrants and equity stakes in its portfolio companies for additional upside potential. Thanks to its monthly dividend policy, the stock is consistently mentioned among income-focused investors.
Over the past 1 year, on the lower side
39% below its 1-year high.
Traded less than usual. That is 77% of its average volume.
Next earnings report: November 5
5 days to go. The ex-dividend date is November 17.
HRZN earns at a steady pace
Of every $100 in sales, $102.00 is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -35.7% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $1,204. Peers typically go for $1,169. Compared with its own 1-year average, it is 1211% pricier now.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -75.5%. The S&P 500 did +65% over the same period.
Tap to view numbers
Dividends are high, but the share price has crashed
Yields 23.22% a year, but the share price is -36.2% over the past year.
Tap to view numbers
Ownership is about average
Institutions hold 11.6%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #88 of 137 in the industry
Based on market cap of $273M.
FAQ
What kind of company is HRZN?
HRZN belongs to the Financial sector and operates in the Asset Management industry.
What is the market cap of HRZN?
The market cap of HRZN is approximately $273M, ranking 3,744 within its sector.
Does HRZN pay dividends?
HRZN has a dividend yield of approximately 23.22%, with an annual dividend of $0.94.
What is the P/E ratio of HRZN?
HRZN has a P/E ratio of approximately 12.4x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for HRZN?
HRZN has recorded a 52-week high of $6.63 and a low of $3.68.